Results 361 to 370 of about 593,453 (414)

A learning health system model for addressing substance use: Denver Health Center for Addiction Medicine

Learning Health Systems, EarlyView.
Abstract Introduction Substance use disorders (SUDs) continue to place heavy burdens on patients, health systems, and communities. Rapidly evolving treatment for SUDs requires health systems that can efficiently and effectively assess data and integrate evidence to practice.
Emily Bacon, Laura J. Podewils, Brooke Bender, Joshua Blum, Christian Thurstone, Alia Al‐Tayyib, John Mills, Alexandra R. Tillman, Judith Shlay   +8 more
wiley   +1 more source

Opioid use and adverse health effects in breast cancer survivors. [PDF]

Oncologist
Haque R, Chen LH, Shi J, Gu Z, Brady-Rogers M, Chlebowski RT, Hechter RC.   +6 more
europepmc   +1 more source

Naloxone Knowledge, Carrying, Purchase, and Use.

JAMA Netw Open
Jacobson M, Powell D.
europepmc   +1 more source

Difficulties with prescribed opioids: a cross-sectional survey of primary care patients in England, United Kingdom. [PDF]

Pain Rep
Wilson LE, Knaggs RD, Avery AJ, Thornley T, Moss J, Baamer RM, Boyd MJ.   +6 more
europepmc   +1 more source

Prehospital Use of Medication-Assisted Treatment for Opioid Use Disorder: A Rapid Review of Implementation Approaches and Outcomes. [PDF]

Subst Abuse Rehabil
Denton EE, Ventura CAI.
europepmc   +1 more source

Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia's drug supply. [PDF]

Harm Reduct J
Wallace B, Shkolnikov I, Kielty C, Robinson D, Gozdzialski L, Joshua J, Margolese A, Gonzalez-Nieto P, Saatchi A, Abruzzi L, Zarkovic T, Gill C, Hore D.   +12 more
europepmc   +1 more source

Effectiveness of Generative Artificial Intelligence-Driven Responses to Patient Concerns in Long-Term Opioid Therapy: Cross-Model Assessment. [PDF]

Biomedicines
Lo Bianco G, Robinson CL, D'Angelo FP, Cascella M, Natoli S, Sinagra E, Mercadante S, Drago F.   +7 more
europepmc   +1 more source

Factors contributing to the expansion of medication for opioid use disorder (MOUD) within the New Hampshire Department of Corrections (NHDOC). [PDF]

Health Justice
Clayman N, Eamranond P, Hanks H, Mitcheff M, RappaMannion L, York D, Mattis P, Guinen H, Carp A, Olson L, Bell K, Shahi L, Saunders E, Lee J, Marsch L.   +14 more
europepmc   +1 more source

Medicare Beneficiary Receipt of Methadone by Drive Time to Opioid Treatment Programs.

JAMA Netw Open
Cantor J, Hernandez HG, Kofner A, Lai J, Agniel D, Simon KI, Stein BD, Taylor EA.   +7 more
europepmc   +1 more source